Ming‐Ling Chang

2.6k total citations
121 papers, 1.9k citations indexed

About

Ming‐Ling Chang is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Ming‐Ling Chang has authored 121 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Epidemiology, 90 papers in Hepatology and 19 papers in Surgery. Recurrent topics in Ming‐Ling Chang's work include Liver Disease Diagnosis and Treatment (73 papers), Hepatitis C virus research (68 papers) and Hepatitis B Virus Studies (51 papers). Ming‐Ling Chang is often cited by papers focused on Liver Disease Diagnosis and Treatment (73 papers), Hepatitis C virus research (68 papers) and Hepatitis B Virus Studies (51 papers). Ming‐Ling Chang collaborates with scholars based in Taiwan, United States and Sweden. Ming‐Ling Chang's co-authors include Yun‐Fan Liaw, Chau‐Ting Yeh, Sien‐Sing Yang, Rong‐Nan Chien, Chao‐Wei Hsu, Stephanos J. Hadziyannis, Kung‐Hao Liang, Ming‐Wei Lai, Yi‐Cheng Chen and Zinger Yang and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Ming‐Ling Chang

117 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming‐Ling Chang Taiwan 22 1.2k 1.1k 302 205 157 121 1.9k
Pascal Lapierre Canada 24 856 0.7× 1.0k 0.9× 325 1.1× 240 1.2× 120 0.8× 47 1.8k
Masaru Enomoto Japan 27 1.6k 1.3× 1.6k 1.4× 441 1.5× 236 1.2× 330 2.1× 165 2.6k
Masaaki Korenaga Japan 24 1.6k 1.3× 1.5k 1.3× 418 1.4× 135 0.7× 84 0.5× 79 2.4k
Yedidya Saiman United States 14 767 0.6× 798 0.7× 282 0.9× 209 1.0× 84 0.5× 22 1.4k
Fusao Ikeda Japan 26 1.3k 1.0× 1.5k 1.3× 320 1.1× 268 1.3× 142 0.9× 115 2.3k
Aldo Marrone Italy 22 1.3k 1.1× 1.2k 1.1× 235 0.8× 118 0.6× 68 0.4× 81 2.0k
Masahiko Kaito Japan 29 1.5k 1.2× 1.3k 1.2× 539 1.8× 199 1.0× 114 0.7× 85 2.8k
Ming‐Chao Tsai Taiwan 21 948 0.8× 896 0.8× 245 0.8× 144 0.7× 195 1.2× 104 1.4k
Yoshihiko Yano Japan 23 1.0k 0.8× 897 0.8× 204 0.7× 151 0.7× 66 0.4× 152 1.7k
Shingo Nakamoto Japan 23 844 0.7× 1.0k 0.9× 245 0.8× 144 0.7× 138 0.9× 107 1.6k

Countries citing papers authored by Ming‐Ling Chang

Since Specialization
Citations

This map shows the geographic impact of Ming‐Ling Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Ling Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Ling Chang more than expected).

Fields of papers citing papers by Ming‐Ling Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming‐Ling Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Ling Chang. The network helps show where Ming‐Ling Chang may publish in the future.

Co-authorship network of co-authors of Ming‐Ling Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Ming‐Ling Chang. A scholar is included among the top collaborators of Ming‐Ling Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming‐Ling Chang. Ming‐Ling Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chang, Ming‐Ling, Puo‐Hsien Le, Wei‐Ting Chen, et al.. (2024). Distinct characteristics of various autoimmune liver diseases: A 22‐year hospital‐based study in Taiwan. Journal of Gastroenterology and Hepatology. 39(12). 2835–2844. 2 indexed citations
2.
Chang, Ming‐Ling, Jur‐Shan Cheng, Wei‐Ting Chen, et al.. (2024). Long-term renal function alterations in hepatitis C patients with SVRs: Impacts of therapies and mixed cryoglobulinemia. Journal of Infection and Public Health. 17(3). 486–494. 2 indexed citations
3.
Chen, Tsung‐Hsing, Hung‐Chih Hsu, Jeng‐Fu You, et al.. (2023). Extracellular Nicotinamide Phosphoribosyltransferase as a Surrogate Marker of Prominent Malignant Potential in Colonic Polyps: A 2-Year Prospective Study. Cancers. 15(6). 1702–1702. 2 indexed citations
4.
Kuo, Chia‐Jung, Wey‐Ran Lin, Ming‐Ling Chang, et al.. (2023). Molecular characterization of rifabutin-resistance in refractory Helicobacter pylori infection in Taiwan. International Journal of Infectious Diseases. 138. 25–28.
5.
Huang, Yung‐Hsin, Chao‐Wei Hsu, Yi‐Cheng Chen, et al.. (2023). Hepatitis C micro-elimination through the retrieval strategy of patients lost to follow-up. BMC Gastroenterology. 23(1). 40–40. 6 indexed citations
6.
Chen, Wei‐Ting, Shi‐Ming Lin, Wei‐Chen Lee, et al.. (2022). GALNT14 genotype-guided chemoembolization plus sorafenib therapy in hepatocellular carcinoma: a randomized trial. Hepatology International. 16(1). 148–158. 11 indexed citations
7.
Chang, Ming‐Ling, et al.. (2022). Thrombin-Activated Platelets Protect Vascular Endothelium against Tumor Cell Extravasation by Targeting Endothelial VCAM-1. International Journal of Molecular Sciences. 23(7). 3433–3433. 3 indexed citations
8.
Chu, Yin‐Yi, Jur‐Shan Cheng, Ting‐Shu Wu, et al.. (2021). Association between Hepatitis C Virus Infection and Esophageal Cancer: An Asian Nationwide Population-Based Cohort Study. Journal of Clinical Medicine. 10(11). 2395–2395. 4 indexed citations
9.
Kuo, Chia‐Jung, Cheng‐Han Lee, Ming‐Ling Chang, et al.. (2021). Multidrug resistance: The clinical dilemma of refractory Helicobacter pylori infection. Journal of Microbiology Immunology and Infection. 54(6). 1184–1187. 28 indexed citations
10.
Lin, Chih‐Lang, Chao‐Wei Hsu, Ming‐Ling Chang, et al.. (2019). Decreasing seroprevalence of anti‐hepatitis D virus antibodies in the antiviral era with inverse association with hepatitis B virus DNA, Taiwan, 2006 to 2019. Journal of Medical Virology. 92(1). 124–127. 3 indexed citations
11.
Lin, Chen‐Chun, Chao‐Wei Hsu, Yi‐Cheng Chen, et al.. (2019). A GALNT14 rs9679162 genotype-guided therapeutic strategy for advanced hepatocellular carcinoma: systemic or hepatic arterial infusion chemotherapy. The Pharmacogenomics Journal. 20(1). 57–68. 10 indexed citations
12.
Chang, Su‐Wei, Mei‐Ling Cheng, Ming‐Shi Shiao, et al.. (2018). Recovery of lipid metabolic alterations in hepatitis C patients after viral clearance: Incomplete restoration with accelerated ω-oxidation. Journal of clinical lipidology. 12(3). 756–766. 11 indexed citations
13.
Lin, Wey‐Ran, Chao‐Wei Hsu, Yi‐Cheng Chen, et al.. (2017). Combinations of single nucleotide polymorphisms WWOX‐rs13338697, GALNT14‐rs9679162 and rs6025211 effectively stratify outcomes of chemotherapy in advanced hepatocellular carcinoma. Asia-Pacific Journal of Clinical Oncology. 14(2). e54–e63. 10 indexed citations
14.
15.
Hu, Jinghong, Mei‐Yen Chen, Chau‐Ting Yeh, et al.. (2016). Sexual Dimorphic Metabolic Alterations in Hepatitis C Virus-infected Patients. Medicine. 95(18). e3546–e3546. 18 indexed citations
16.
Chang, Ming‐Ling, Chee‐Jen Chang, Tse‐Ching Chen, et al.. (2013). Occult and Overt HBV Co-Infections Independently Predict Postoperative Prognosis in HCV-Associated Hepatocellular Carcinoma. PLoS ONE. 8(6). e64891–e64891. 14 indexed citations
17.
Cheng, Jinming, et al.. (2011). Hepatic expression of MxA and OAS1 in an ex vivo liver slice assay independently predicts treatment outcomes in chronic hepatitis C. Journal of Viral Hepatitis. 19(2). e154–62. 8 indexed citations
18.
Chang, Ming‐Ling, et al.. (2009). Cell cycle perturbation in the hepatocytes of HCV core transgenic mice following common bile duct ligation is associated with enhanced p21 expression. Journal of Medical Virology. 81(3). 467–472. 9 indexed citations
19.
20.
Chang, Ming‐Ling. (2005). Comparison of murine cirrhosis models induced by hepatotoxin administration and common bile duct ligation. World Journal of Gastroenterology. 11(27). 4167–4167. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pascal Lapierre Breakdown of academic impact, for papers by Masaru Enomoto Breakdown of academic impact, for papers by Masaaki Korenaga Breakdown of academic impact, for papers by Yedidya Saiman Breakdown of academic impact, for papers by Fusao Ikeda Breakdown of academic impact, for papers by Aldo Marrone Breakdown of academic impact, for papers by Masahiko Kaito Breakdown of academic impact, for papers by Ming‐Chao Tsai Breakdown of academic impact, for papers by Yoshihiko Yano Breakdown of academic impact, for papers by Shingo Nakamoto
Rankless by CCL
2026